Select Publications
Book Chapters
, 2025, 'Heart transplantation', in Oh S Intensive Care Manual, pp. 1327 - 1335, http://dx.doi.org/10.1016/B978-0-443-11611-7.00117-1
, 2024, 'Clinical/Cardiovascular/Cardiopulmonary Bypass: Effect of Alteration in Pump Speed on Pump Output and Left Ventricular Filling with Continuous-Flow Left Ventricular Assist Device', in American Society for Artificial Internal Organs (ASAIO) Platinum 70th Anniversary Special Edition, CRC Press, pp. 238 - 242, http://dx.doi.org/10.1201/9781003543480-37
, 2024, 'Ex-vivo organ support', in Mechanical Circulatory and Respiratory Support, pp. 83 - 119, http://dx.doi.org/10.1016/B978-0-443-22148-4.00003-4
, 2021, 'Repairing cardiac allografts on ex situ perfusion devices', in Organ Repair and Regeneration Preserving Organs in the Regenerative Medicine Era, pp. 213 - 230, http://dx.doi.org/10.1016/B978-0-12-819451-5.00010-X
, 2019, 'Haemodynamic evaluation of the heart transplant patient', in Interventional Cardiology and Cardiac Catheterisation, Taylor & Francis, pp. 417 - 425, http://dx.doi.org/10.1201/9781351060356-29
, 2018, 'HFrEF other treatment: transplantation', in The ESC Textbook of Cardiovascular Medicine, Oxford University Press, http://dx.doi.org/10.1093/med/9780198784906.003.0433
, 2013, 'Assessment, monitoring, and management of brain-dead potential organ donors in Australia', in Brain Dead Organ Donor Pathophysiology and Management, pp. 237 - 249, http://dx.doi.org/10.1007/978-1-4614-4304-9_19
, 2013, 'Heart and lung transplantation', in Oh S Intensive Care Manual Seventh Edition, pp. 1053 - 1067, http://dx.doi.org/10.1016/B978-0-7020-4762-6.00102-8
, 2011, 'Dyspnoea', in Supportive Care in Heart Failure, http://dx.doi.org/10.1093/acprof:oso/9780198570288.003.0009
, 2008, 'Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases', in Clinical Proteomics from Diagnosis to Therapy, pp. 571 - 592, http://dx.doi.org/10.1002/9783527622153.ch31
, 2008, 'Actin and Its Binding Proteins in Heart Failure', in Actin-Binding Proteins and Disease, Springer New York, pp. 318 - 334, http://dx.doi.org/10.1007/978-0-387-71749-4_14
, 1998, 'Increased Nitric Oxide Production in Heart Failure and Correlation with Functional Severity', in Vascular Endothelium, Springer Nature, pp. 283 - 284, http://dx.doi.org/10.1007/978-1-4899-0133-0_43
, 1998, 'The Role of Nitric Oxide Production during Cardiac Allograft Rejection', in Vascular Endothelium, Springer Nature, pp. 281 - 282, http://dx.doi.org/10.1007/978-1-4899-0133-0_42
Journal articles
, 2026, 'Anaesthetics considerations for organ retrieval in the voluntary assisted dying patient – case report', BMC Anesthesiology, 26, http://dx.doi.org/10.1186/s12871-026-03921-w
, 2026, 'Glucagon-like peptide-1 receptor agonists for weight loss in end-stage heart failure patients considered for heart transplantation', Jhlt Open, 13, http://dx.doi.org/10.1016/j.jhlto.2026.100559
, 2026, 'Consolidating Concepts From Recent International Expert Consensus on Sarcopenia: Implications for Heart Failure Management', Journal of Cardiac Failure, 32, pp. 1257 - 1266, http://dx.doi.org/10.1016/j.cardfail.2025.03.021
, 2026, 'Cardiovascular magnetic resonance feature tracking for rejection surveillance after cardiac transplantation', Journal of Cardiovascular Magnetic Resonance, 28, http://dx.doi.org/10.1016/j.jocmr.2025.102675
, 2026, 'Design and Rationale of the FICAPP Study: Frailty in Cardiac Amyloidosis: Profiling the Phenotype', Heart Lung and Circulation, 35, pp. 778 - 786, http://dx.doi.org/10.1016/j.hlc.2026.03.054
, 2026, 'Frailty Response in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation (FRAIL-AS Response Trial): Study Protocol for a Cluster Randomised Controlled Trial', Heart Lung and Circulation, 35, pp. 787 - 794, http://dx.doi.org/10.1016/j.hlc.2026.04.114
, 2026, 'Improving End-of-Life Care for Patients in Australian Cardiology Wards: A Retrospective Medical Record Audit', Heart Lung and Circulation, 35, pp. 845 - 854, http://dx.doi.org/10.1016/j.hlc.2026.04.111
, 2026, 'Opportunities and Risks of Integrating Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Heart Failure Management', Heart Lung and Circulation, 35, pp. 713 - 715, http://dx.doi.org/10.1016/j.hlc.2026.05.004
, 2026, 'Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy', Journal of Antimicrobial Chemotherapy, 81, http://dx.doi.org/10.1093/jac/dkag168
, 2026, 'Assessing the Viability of Hearts Donated After Circulatory Death', Transplantation, 110, pp. e1155 - e1156, http://dx.doi.org/10.1097/TP.0000000000005720
, 2026, 'Authors’ Perspective—Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update', Journal of Heart and Lung Transplantation, 45, pp. 719 - 723, http://dx.doi.org/10.1016/j.healun.2025.12.028
, 2026, 'Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update', Journal of Heart and Lung Transplantation, 45, pp. e149 - e171, http://dx.doi.org/10.1016/j.healun.2025.12.029
, 2026, 'Heterogeneity in Treatment Effects in the Reduction of Dietary Sodium to Less Than 100 mmol in Heart Failure (SODIUM-HF): A Secondary Post Hoc Analysis', Journal of Cardiac Failure, 32, pp. 371 - 381, http://dx.doi.org/10.1016/j.cardfail.2025.01.027
, 2026, 'Feasibility of a Mobile-Based Home Monitoring System for Patients With Heart Failure: Mixed Methods Pilot Study', Jmir Human Factors, 13, http://dx.doi.org/10.2196/84309
, 2026, 'Low transplantation rate in the contemporary Fontan cohort: A marker of success or a reflection of unmet need?', Jtcvs Open, http://dx.doi.org/10.1016/j.xjon.2026.102049
, 2026, 'Association of Mild Cognitive Impairment With Physical Frailty in Transthyretin Amyloid Cardiomyopathy', Heart Lung and Circulation, 35, pp. s316 - s317, http://dx.doi.org/10.1016/j.hlc.2026.07.447
, 2026, 'Beyond Graft Dysfunction: Spontaneous Adrenal Haemorrhage as a Cause of Shock After Heart Transplantation for Cardiac AL Amyloidosis', Heart Lung and Circulation, 35, pp. s217, http://dx.doi.org/10.1016/j.hlc.2026.07.267
, 2026, 'Five-Year Safety Outcomes Analysis of Cardiovascular Magnetic Resonance-Guided Rejection Surveillance After Cardiac Transplantation: The NIDACT-2 Study', Heart Lung and Circulation, 35, pp. s80, http://dx.doi.org/10.1016/j.hlc.2026.07.017
, 2026, 'Frailty Across National Amyloidosis Centre Stages in Transthyretin Amyloidosis Cardiomyopathy', Heart Lung and Circulation, 35, pp. s240, http://dx.doi.org/10.1016/j.hlc.2026.07.304
, 2026, 'Hi1a delivered in various modes reduces myocardial infarct size in mice', Journal of Molecular and Cellular Cardiology Plus, 15, pp. 100753, http://dx.doi.org/10.1016/j.jmccpl.2025.100753
, 2026, 'Impact of Preoperative Frailty on Patient Outcomes Following Transcatheter Aortic Valve Implantation: Analysis of 24,610 Participants From the Australian Transcatheter Valve Therapies Registry', Heart Lung and Circulation, 35, pp. s95 - s96, http://dx.doi.org/10.1016/j.hlc.2026.07.044
, 2026, 'Intraperitoneal administration of empagliflozin reduces myocardial infarct size in mice', Journal of Molecular and Cellular Cardiology Plus, 15, pp. 100750, http://dx.doi.org/10.1016/j.jmccpl.2025.100750
, 2026, 'Long-Term Outcomes From a Decade of Donation After Circulatory Death Heart Transplantation in Australia', JACC Heart Failure, pp. 103168, http://dx.doi.org/10.1016/j.jchf.2026.103168
, 2026, 'Optimising Tacrolimus Dosing for Heart Transplant Patients Upon Cessation of Posaconazole Therapy (Opti-TAC)', Heart Lung and Circulation, 35, pp. s636, http://dx.doi.org/10.1016/j.hlc.2026.07.1020
, 2026, 'P2.245: Diabetes and microalbuminuria in heart transplant recipients – insights from baseline characteristics of the Empagliflozin in Heart Transplant (EMPA-HTx) trial.', Transplantation, 110, http://dx.doi.org/10.1097/01.tp.0001253032.09858.25
, 2026, 'Predictors of Frailty in Transthyretin Amyloidosis Cardiomyopathy: A Real-World Australian Cohort', Heart Lung and Circulation, 35, pp. s257, http://dx.doi.org/10.1016/j.hlc.2026.07.337
, 2026, 'Prospective Evaluation of Non-HLA Antibodies in Heart Transplant Recipients', Heart Lung and Circulation, 35, pp. s262 - s263, http://dx.doi.org/10.1016/j.hlc.2026.07.348
, 2026, 'Refractory Ventricular Tachycardia Stabilising After Cardiac Resynchronisation Therapy-Pacemaker Upgrade in Giant Cell Myocarditis presenting With Complete Heart Block', Heart Lung and Circulation, 35, pp. s264, http://dx.doi.org/10.1016/j.hlc.2026.07.352
, 2025, 'Titin-related familial dilated cardiomyopathy: factors associated with disease onset', European Heart Journal, 46, pp. 5240 - 5257, http://dx.doi.org/10.1093/eurheartj/ehaf380
, 2025, 'Frailty and obesity in heart transplant recipients: impact on post-transplant mortality', European Heart Journal, 46, http://dx.doi.org/10.1093/eurheartj/ehaf784.1357
, 2025, 'Diabetes is an Increasingly Common Issue After Heart Transplantation: A Case for Integrated Diabetes Care', Heart Lung and Circulation, 34, pp. 1290 - 1294, http://dx.doi.org/10.1016/j.hlc.2025.04.081
, 2025, 'Sodium glucose cotransporter 2 inhibitor use after heart transplant: Current knowledge and potential applications', American Journal of Transplantation, 25, pp. 2303 - 2312, http://dx.doi.org/10.1016/j.ajt.2025.08.013
, 2025, 'MON-567 Diabetes After Heart Transplantation Is an Increasingly Common Issue', Journal of the Endocrine Society, 9, http://dx.doi.org/10.1210/jendso/bvaf149.933
, 2025, 'Increasing HOPE for DCD Heart Transplantation', Transplantation, 109, pp. 1574 - 1575, http://dx.doi.org/10.1097/TP.0000000000005431
, 2025, 'Pulmonary Artery Stenting for Widespread Distal Congenital Stenoses', Jacc Case Reports, 30, http://dx.doi.org/10.1016/j.jaccas.2025.105311
, 2025, 'Low-dose apixaban in HeartMate 3 LVAD patients, interim analysis of the ApixiVAD trial, a randomized controlled study', Journal of Heart and Lung Transplantation, 44, pp. 1331 - 1338, http://dx.doi.org/10.1016/j.healun.2025.04.012
, 2025, 'An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National Taskforce', Heart Lung and Circulation, 34, pp. 693 - 703, http://dx.doi.org/10.1016/j.hlc.2025.01.012